Solid lipid nanoparticles and nanosuspension formulation of Saquinavir: preparation, characterization, pharmacokinetics and biodistribution studies

References

• Agueros M, Zabaleta V, Espuelas S, Campanero MA, Irache JM. Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles. J Controlled Rel 2010; 145(1)2–8
   PubMed Web of Science ®Google Scholar
• Arulsudar N, Subramanian N, Mishra P, Sharma RK, Murthy RSR. Preparation characterization and biodistribution of 99mTc-labeled liposome encapsulated cyclosporine. J Drug Target 2003; 11: 187–96
   PubMed Web of Science ®Google Scholar
• Briesen HV, Ramge P, Kruter J. Controlled release of antiretroviral drugs. AIDS Rev 2000; 2: 31–8
   Google Scholar
• Cavalli R. The effect of components of microemulsions on both size and crystalline structure of solid lipid nanoparticles (SLN) containing a series of model molecules. Pharmazie 1998; 53: 392–6
   Web of Science ®Google Scholar
• Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001; 13: 123–33
   PubMed Web of Science ®Google Scholar
• Craig JC, Duncan IB, Hockley D, Grief C, Roberts NA, Mills JS. Antiviral properties of Ro 31-8959, an inhibitor of human immunodeficiency virus (HIV) protease. Antiviral Res 1991; 16: 295–305
   PubMed Web of Science ®Google Scholar
• Dupre J, Behme MT, Hramiak IM, Macfarlane P, Williamson MP, Zabel P, Mcdonoland TT. Glucagon-like peptide I reduces postprandial glycemic excursions in IDDM. Diabetes 1995; 44: 626–30
   PubMed Web of Science ®Google Scholar
• Freitas C, Muller RH. Co-relation between long-term stability of solid lipid nanoparticles (SLNs) and crystallinity of the lipid phase. Eur J Pharm Biopharm 1999; 47: 125–32
   PubMed Web of Science ®Google Scholar
• Grant DJW, Brittian HG. Solubility of pharmaceutical solids. Physical Characterization of Pharmaceutical Solids, HG Brittian. Marcel Dekker, New York 1995; 322–80
   Google Scholar
• Hu LD, Tang X, Cue FD. Solid lipid nanoparticles to improve oral bioavailability of poorly soluble drugs. J Pharm Pharmacol 2004; 56: 1527–35
   PubMed Web of Science ®Google Scholar
• Irache G, Poncela J. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv Drug Deliv Rev 1998; 34: 191–219
   PubMed Web of Science ®Google Scholar
• Jani P, Halbert GW, Langridge J, Florence AT. The uptake and translocation of latex nanospheres and microspheres after oral administration to rats. J Pharm Pharmacol 1989; 41: 809–12
   PubMed Web of Science ®Google Scholar
• Kitchen VS, Skinner C, Ariyoshi K, Lane EA, Duncan IB, Burckhardt J. Safety and activity of saquinavir in HIV infection. Lancet 1995; 345: 952–5
   PubMed Web of Science ®Google Scholar
• Kuo Y, Su F. Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles. Int J Pharm 2007; 340(1–2)143–52
   PubMed Web of Science ®Google Scholar
• Lai F, Wissing SA, Muller RH, Fadda AM. Artemisia arborescens L essential oil–loaded solid lipid nanoparticles for potential agricultural application: Preparation and characterization. AAPS PharmSciTech 2006; 7: E1–9
   PubMed Web of Science ®Google Scholar
• Li Y, Taulier N, Rauth AM, Wu X. Screening of lipid carriers and characterization of drug-polymer-lipid interactions for the rational design of polymer-lipid hybrid nanoparticles (PLN). Pharm Res 2006; 23(8)1877–87
   PubMed Web of Science ®Google Scholar
• Maincent P, Thouvenot P. Lymphatic targeting of polymeric nanoparticles after intraperitoneal administration in rats. Pharm Res 1992; 9: 1534–39
   PubMed Web of Science ®Google Scholar
• Manjunath K, Venkateswarlu V. Pharmacokinetics tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration. J Controlled Rel 2005; 107: 215–28
   PubMed Web of Science ®Google Scholar
• Mathot F, Beijsterveldt L, Preat V, Brewster M, Arien A. Intestinal uptake and biodistribution of novel polymeric micelles after oral administration. J Controlled Rel 2006; 111: 47–55
   PubMed Web of Science ®Google Scholar
• Muller RH, Mader KS, Gohla A. Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. Eur J Pharm Biopharm 2000; 50: 161–77
   PubMed Web of Science ®Google Scholar
• Noble S, Faulds D. Saquinavir: A review of its pharmacology and clinical potential in the management of HIV infection. Drugs 1996; 52: 93–112
   PubMed Web of Science ®Google Scholar
• Otsuka M, Kaneniwa N. Effect of seed crystals on solid state transformation of polymorphs of chloramphenicol palmitate during grinding. J Pharm Sci 1986; 75: 506–11
   PubMed Web of Science ®Google Scholar
• Palla BJ, Shah DO. Stabilization of high ionic strength slurries using surfactant mixtures: Molecular factors that determine optimal stability. J Colloid Interface Sci 2002; 256: 143–52
   Web of Science ®Google Scholar
• Patravale VB, Date AA, Kulkarni RM. Nanosuspensions: A promising drug delivery strategy. J Pharm Pharmcol 2004; 56: 827–40
   PubMed Web of Science ®Google Scholar
• Reddy LH, Murthy R. Etoposide-loaded nanoparticles made from glyceride lipids: Formulation characterization in vitro drug release and stability evaluation. AAPS PharmSciTech 2005; 6: 158–66
   PubMed Web of Science ®Google Scholar
• Roberts NA, Martin JA, Kinchington D, Broadhurst AV, Craig JC, Duncan IV. Rational design of peptide based HIV protease inhibitors. Science 1993; 248: 358–61
   Google Scholar
• Robins T, Plattner J. HIV protease inhibitors: Their anti-HIV activity and potential role in treatment. J Acquir Immune Defic Syndr 1993; 6: 162–70
   PubMed Web of Science ®Google Scholar
• Sawant KK, Dodiya SS. Recent advances and patents on solid lipid nanoparticles. Recent Pat Drug Deliv Formul 2008; 2: 120–35
   PubMedGoogle Scholar
• Shin S, Bum J, Choi J. Enhanced bioavailability by buccal administration of triamcinolone acetonide from the bioadhesive gel in rabbits. Int J Pharm 2000; 209: 37–43
   PubMed Web of Science ®Google Scholar
• Sigfridsson K, Forresen S, Hollander P, Skantze U, Verdier J. A formulation comparison, using a solution and different nanosuspensions of a poorly soluble compound. Eur J Pharm Biopharm 2007; 67: 540–7
   PubMed Web of Science ®Google Scholar
• Smith A, Giunta B, Bickford PC, Fountain M, Tan J, Shytle RD. Nanolipidic particles improve the bioavailability and α-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease. Int J Pharm 2010; 389(1–2)207–12
   PubMed Web of Science ®Google Scholar
• Su Y, Lee SH, Sinko PJ. Practical aspects of transporter model systems: A case study involving SQV. Drug Metab Rev 2004; 36(2)377–89
   PubMed Web of Science ®Google Scholar
• Taburet AM, Sabine PB, Gilles P, Molina JM. Once daily administration of antiretroviral. Clin Pharmacokinet 2003; 42: 1179–91
   PubMed Web of Science ®Google Scholar
• Tsai Y, Jan W, Chien C, Lee W, Lin L, Tsai T. Optimised nano-formulation on the bioavailability of hydrophobic polyphenol, curcumin, in freely-moving rats. Food Chem 2011; 127(3)918–25
   PubMed Web of Science ®Google Scholar
• Venkataraju MP, Gowda DV, Rajesh KS, Shivakumar HG. Xanthum and locust bean gum (from certonia siliqua) matrix tablets for oral controlled delivery of metoprolol tartarate. Curr Drug Ther 2008; 3: 70–7
   Google Scholar
• Vivek K, Reddy H, Murthy RS. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles. AAPS PharmSciTech 2007; 8(4)E1–7
   PubMedGoogle Scholar
• Vyas T, Sahiwala A, Amili M. Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations. Int J Pharm 2008; 347: 93–101
   PubMed Web of Science ®Google Scholar
• Wu MS, Robbins JC, Ponpinom MM, Shen TV. Modified in vivo behavior of liposomes containing synthetic glycolipids. Biochim Biophys Acta 1981; 674: 19–29
   PubMed Web of Science ®Google Scholar
• Yang S, Zhu J, Lu Y, Liang B, Yang C. Body distribution of camptothecin solid lipid nanoparticles after oral administration. Pharm Res 1999; 16: 751–7
   PubMed Web of Science ®Google Scholar